Lamivudine Sorbitol 701

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 1 dose
300 mg daily
Drug 1 effect

AUC decreased 20-44%

Drug 2
Drug 2 dose
3.2 - 13.4 grams daily
Drug 2 effect

Not studied

Clinical Effects

Potentially decreased lamivudine efficacy

Management

Consider using alternative agents. Interaction studied with liquid formulation. If unable to avoid co-administration, monitor for virologic efficacy.

Import ID
701